Therapeutic effects of icariin and icariside II on diabetes mellitus and its complications

Abstract

Diabetes mellitus (DM) is a global health issue in the twenty-first century, and there are numerous challenges in preventing and alleviating its chronic complications. The herb Epimedium has beneficial therapeutic effects on various human diseases, including DM. Its major flavonoid component, icariin, has significant anti-DM activity and may help improve pancreatic β-cell dysfunction and insulin resistance. Furthermore, preclinical evidence has shown that icariin and its in vivo bioactive form, icariside II, have preventive and therapeutic effects on several diabetic complications, including diabetic cardiomyopathy, diabetic vascular endothelial disorder, diabetic nephropathy, and diabetic erectile dysfunction. In this review, we present the general and toxicological information concerning icariin and icariside II and review the anti-DM effects of icariin from a molecular perspective. Additionally, we discuss the potential benefits of icariin and icariside II on the important pathological mechanisms of various diabetic complications. Despite positive preclinical evidence, additional investigations are needed before relevant clinical studies can be conducted. Therefore, we conclude with suggestions for future research. Hopefully, this review will provide a comprehensive molecular perspective for future research and product development related to icariin and icariside II in treating DM and diabetic complications.

Keywords:

• Diabetes complications
• diabetes mellitus
• icariin
• icariside II
• molecular mechanism
• therapeutic effects

Acknowledgements

The authors would like to thank Professor Huanan Jia of the Department of Geriatrics, Hospital of Chengdu University of Traditional Chinese Medicine, for critically reviewing the manuscript.

Disclosure statement

The authors reported no potential conflict of interest.

Additional information

Funding

This research received no external funding.